International

On Monday, November 23, 2020, the Pharmaceutical Research and Manufacturers of America (PhRMA), along with the Partnership for…

In early September 2020, the Government of Alberta released regulations on physician payment disclosure in what is promised to be…

Recently, the French Competition Authority concluded its investigation into Roche and Novartis for Lucentis marketing missteps,…

On September 13, 2020, United States President Donald Trump signed an Executive Order (EO) to create a “most favored nation” drug…

Recently, Alberta (Canada) Health Minister Tyler Shandro tabled an amendment to proposed Bill 30 – the Health Statutes Amendment…

A new analysis conducted by the Council of Economic Advisers (a White House group that provides the president advice on economic…

On September 23, 2019, the House Ways & Means Committee released a report outlining and comparing the pharmaceutical pricing…

Following a review of pharmaceutical advertising, the UK’s Prescription Medicines Code of Practice Authority (“PMCPA”) cited…

In early August 2019, the Canadian government announced regulations to reduce patented drug prices, with the intent to save…

This summer has been the summer of reimportation with the Trump administration proposing pathways for national reimportation.  The…